NCT05253235 Health and Resilience Projects: Foundations
| NCT ID | NCT05253235 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Georgia |
| Condition | Substance Use |
| Study Type | INTERVENTIONAL |
| Enrollment | 650 participants |
| Start Date | 2022-01-25 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 650 participants in total. It began in 2022-01-25 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Health and Resilience Project (HARP): Foundations is investigating the efficacy of the Strong African American Families (SAAF) intervention in promoting the health and well being of African American adolescents. Youth age 10-13 and their primary caregivers are randomly assigned to receive SAAF or to a control group. Participants complete baseline and follow-up measures regarding vulnerability to substance use based on a neuroimmune model of stress coping.
Eligibility Criteria
Inclusion Criteria: Youth: * Self reported African American or Black; * Age 10-13 Parents: * Primary caregiver for youth, * Resides in same household as youth. Exclusion Criteria: Youth : * Contraindications for MRI scanning (e.g., metal in body, traumatic brain injury, claustrophobia, pregnancy), * Youth with chronic illnesses or medication regimens that would affect inflammatory panels (e.g., diabetes, congenital heart disease, asthma, cancers). Parent: * Conditions (e.g., severe disability, psychoses) that would prevent participation in the SAAF intervention or completing self-report measures.
Contact & Investigator
Gene H Brody, Ph.D.
PRINCIPAL INVESTIGATOR
University of Georgia
Frequently Asked Questions
Who can join the NCT05253235 clinical trial?
This trial is open to participants of all sexes, aged 10 Years or older, up to 13 Years, studying Substance Use. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05253235 currently recruiting?
Yes, NCT05253235 is actively recruiting participants. Contact the research team at zuercher@uga.edu for enrollment information.
Where is the NCT05253235 trial being conducted?
This trial is being conducted at Athens, United States.
Who is sponsoring the NCT05253235 clinical trial?
NCT05253235 is sponsored by University of Georgia. The principal investigator is Gene H Brody, Ph.D. at University of Georgia. The trial plans to enroll 650 participants.